TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 54 filers reported holding TOKAI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $9,000 | -72.7% | 6,000 | 0.0% | 0.00% | -75.0% |
| Q2 2016 | $33,000 | -2.9% | 6,000 | 0.0% | 0.01% | -20.0% |
| Q1 2016 | $34,000 | -34.6% | 6,000 | 0.0% | 0.02% | -34.8% |
| Q4 2015 | $52,000 | -16.1% | 6,000 | 0.0% | 0.02% | -30.3% |
| Q3 2015 | $62,000 | -22.5% | 6,000 | 0.0% | 0.03% | -23.3% |
| Q2 2015 | $80,000 | – | 6,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 511,010 | $2,815,665,000 | 0.61% |
| Perceptive Advisors | 661,041 | $3,642,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 749,205 | $4,128,000 | 0.22% |
| Novo Holdings A/S | 128,993 | $711,000 | 0.08% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $193,000 | 0.04% |
| Alyeska Investment Group, L.P. | 322,297 | $1,776,000 | 0.02% |
| PARADIGM ASSET MANAGEMENT CO LLC | 17,600 | $96,976,000 | 0.02% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $33,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $551,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,262 | $17,000 | 0.00% |